NEW YORK (GenomeWeb) – Era7 Bioinformatics today announced a $400,000 investment in the firm by Comercial Rafer to help accelerate the international expansion of the company.

Era7, which is based in Spain, said that it specifically wants to expand its operations in the US, where it has a subsidiary headquartered in Cambridge, Mass. It and Comercial Rafer have also reached a distribution agreement for Era7's services covering Spain and Portugal, Era7 CEO Eduardo Pareja said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.